WHAT DOES IT MEAN TO BE A CANCER GENE CARRIER - PROBLEMS IN ESTABLISHING CAUSALITY FROM THE MOLECULAR-GENETICS OF CANCER

被引:20
作者
SCHATZKIN, A
GOLDSTEIN, A
FREEDMAN, LS
机构
[1] NCI,DIV CANC PREVENT & CONTROL,CANC PREVENT STUDIES BRANCH,BETHESDA,MD 20892
[2] NCI,DIV CANC PREVENT & CONTROL,BIOMETRY BRANCH,BETHESDA,MD 20892
[3] NCI,DIV CANC ETIOL,GENET EPIDEMIOL BRANCH,BETHESDA,MD 20892
关键词
D O I
10.1093/jnci/87.15.1126
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article addresses the following question: What does it mean to be a cancer gene carrier? The existence of families prone to cancer has prompted an intense search for predisposing heritable gene mutations. Genes that impart susceptibility to colorectal, breast, and ovarian cancers have been recently identified. It is doubtful, however, that the action of a single mutant gene totally accounts for the development of malignant disease. The mutant gene likely causes cancer in these family members only in conjunction with other genes, environmental factors, or both. Furthermore, although an individual carrier of a mutant gene within a cancer-prone family has an increased risk of malignancy, nutritional, pharmacologic, or other interventions may still confer protection. Extrapolations from cancer-prone families to the general population are even more problematic. The excess risk of malignancy among carriers of mutant genes who are not members of cancer-prone families is unknown. Large-scale epidemiologic studies are needed to determine the magnitude (or even the existence) of such excess risk.
引用
收藏
页码:1126 / 1130
页数:5
相关论文
共 35 条
[1]  
Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649
[2]   MILD CYSTIC-FIBROSIS IN CHILD HOMOZYGOUS FOR G542 NONSENSE MUTATION IN CF GENE [J].
BONDUELLE, M ;
LISSENS, W ;
LIEBAERS, I ;
MALFROOT, A ;
DAB, I .
LANCET, 1991, 338 (8760) :189-189
[3]   MUTATION IN THE DNA MISMATCH REPAIR GENE HOMOLOG HMLH1 IS ASSOCIATED WITH HEREDITARY NONPOLYPOSIS COLON-CANCER [J].
BRONNER, CE ;
BAKER, SM ;
MORRISON, PT ;
WARREN, G ;
SMITH, LG ;
LESCOE, MK ;
KANE, M ;
EARABINO, C ;
LIPFORD, J ;
LINDBLOM, A ;
TANNERGARD, P ;
BOLLAG, RJ ;
GODWIN, AR ;
WARD, DC ;
NORDENSKJOLD, M ;
FISHEL, R ;
KOLODNER, R ;
LISKAY, RM .
NATURE, 1994, 368 (6468) :258-261
[4]   MILD PULMONARY-DISEASE IN A CYSTIC-FIBROSIS CHILD HOMOZYGOUS FOR R553X [J].
CHEADLE, J ;
ALJADER, L ;
GOODCHILD, M ;
MEREDITH, AL .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (08) :597-597
[5]   AGE AT ONSET AS AN INDICATOR OF FAMILIAL RISK OF BREAST-CANCER [J].
CLAUS, EB ;
RISCH, NJ ;
THOMPSON, D .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (06) :961-972
[6]  
DEAN M, 1994, HUM GENET, V93, P364
[7]   GENETIC IDENTIFICATION OF MOM-1, A MAJOR MODIFIER LOCUS AFFECTING MIN-INDUCED INTESTINAL NEOPLASIA IN THE MOUSE [J].
DIETRICH, WF ;
LANDER, ES ;
SMITH, JS ;
MOSER, AR ;
GOULD, KA ;
LUONGO, C ;
BORENSTEIN, N ;
DOVE, W .
CELL, 1993, 75 (04) :631-639
[8]  
EASTON DF, 1993, AM J HUM GENET, V52, P678
[9]   THE HUMAN MUTATOR GENE HOMOLOG MSH2 AND ITS ASSOCIATION WITH HEREDITARY NONPOLYPOSIS COLON-CANCER [J].
FISHEL, R ;
LESCOE, MK ;
RAO, MRS ;
COPELAND, NG ;
JENKINS, NA ;
GARBER, J ;
KANE, M ;
KOLODNER, R .
CELL, 1993, 75 (05) :1027-1038
[10]  
FISHEL R, 1994, CELL, V77, P167